Galantamine functions as a reversible, competitive acetylcholinesterase inhibitor for cognitive maintenance. It also acts as an allosteric modulator of nicotinic receptors, augmenting cholinergic neurotransmission to support cerebral integrity.
Galantamine belongs to the class of reversible cholinesterase inhibitors, a group of compounds that influence nerve-cell communication. It is the active substance found in several products marketed as Galantamine tablets and oral solutions. The primary therapeutic purpose of this compound is to support cognitive function in individuals experiencing certain neurodegenerative conditions.
In Singapore, Galantamine appears mainly as immediate-release tablets and, in some cases, as oral liquid preparations. Both generic versions and brand-named products carry the same active ingredient, differing mainly in appearance and excipients. These medicines are regulated by the Health Sciences Authority and are dispensed through pharmacies following a healthcare professional’s order.
The compound is most frequently associated with the management of mild to moderate cognitive decline linked to Alzheimer’s disease. It may also be considered for:
Its use is generally directed at adults who show measurable deficits in memory, reasoning, or language that interfere with routine tasks.
Galantamine blocks the enzyme that breaks down acetylcholine, a neurotransmitter vital for learning and memory. By slowing this breakdown, higher levels of acetylcholine remain available at synaptic junctions, helping to sustain neuronal signaling. This modest boost can translate into steadier performance on tasks that require attention and recall.
These uncommon occurrences warrant immediate medical assessment.
For a complete list of possible interactions, refer to the specific medication’s detailed information sheet.
Galantamine tablets should be stored at room temperature, away from direct sunlight and moisture. The typical treatment course can range from short-term trials to prolonged administration, depending on the underlying condition and patient response. Dosage strength and treatment length may differ among the various Galantamine products available locally. For detailed usage, dosing, and administration, refer to the specific medication’s clinical information.
This article provides an educational overview of galantamine as an active compound and does not constitute medical advice. Individual medicines containing galantamine may vary in formulation, strength, and instructions for use. The information presented here is not a substitute for professional judgment, and liability for clinical application is expressly disclaimed. Patients should read the labeling of their specific product and seek guidance from a healthcare professional when making decisions about treatment.